Development and Validation of an Improved RP-HPLC Method for the Quantitative Determination of Flunarizine in Bulk and Tablet Dosage Form

P. Ravisankar,G. D. Rao,M. Chaitanya

Abstract:An accurate, simple, sensitive, selective, economic reversed phase high performance liquid chromatographic (RP-HPLC) method has been developed and validated for determination of flunarizine in its bulk form and pharmaceutical preparations. The chromatographic separation was achieved using Welchrom C18 isocratic column, (250 mm × 4.6 mm i.d., particle size 5 μm, maintained at ambient temperature), Shimadzu LC20AT Prominence Liquid Chromatograph. The mobile phase containing a mixture of Methanol: Acetonitrile: Water 50:30:20 v/v, with apparent pH of 4.6 and a flow rate of 1.0 ml/min. The UV detection was set at 245 nm. The method was linear, regression coefficient (0.9998) at a concentration range of 2 - 10 μg/ml. The limit of detection and limit of quantitation for the method were 0.101629μg/ml and 0.307968μg/ml, respectively. The intra- and inter-assay precisions were satisfactory; the values of relative standard deviations did not exceed 2%. The accuracy of the method was proved; the mean recovery of flunarizine was 99.07% to 100.35%. The chromatographic retention time of proposed method was 6.023 min. Validation studies were performed according to ICH Guidelines revealed that the proposed method is specific, rapid, reliable and reproducible. The proposed method was successfully applied for the determination of flunarizine in its bulk form and pharmaceutical tablets with phenomenal accuracy and precisions. The label claim percentages were 100.47 ± 0.79 %. The proposed method is selective and involved simple procedures and this method is practical and valuable for routine application in quality control laboratories for determination of flunarizine.